» Articles » PMID: 36826013

Anxiety and Metabolic Disorders: The Role of Botanicals

Overview
Publisher MDPI
Specialty Molecular Biology
Date 2023 Feb 24
PMID 36826013
Authors
Affiliations
Soon will be listed here.
Abstract

Anxiety and anxiety-related disorders are becoming more evident every day, affecting an increasing number of people around the world. Metabolic disorders are often associated with anxiety. Furthermore, anxiety branches into metabolic disorders by playing multiple roles as a cofactor, symptom, and comorbidity. Taken together, these considerations open the possibility of integrating the therapy of metabolic disorders with specific drugs for anxiety control. However, anxiolytic compounds often cause disabling effects in patients. The main goal could be to combine therapeutic protocols with compounds capable of reducing side effects while performing multiple beneficial effects. In this article we propose a group of bioactive ingredients called botanicals as a healthy supplement for the treatment of metabolic disorders related to anxiety.

Citing Articles

Unveiling Niaprazine's Potential: Behavioral Insights into a Re-Emerging Anxiolytic Agent.

Trebesova H, Monaco M, Baldassari S, Ailuno G, Lancellotti E, Caviglioli G Biomedicines. 2024; 12(9).

PMID: 39335600 PMC: 11428487. DOI: 10.3390/biomedicines12092087.


Editorial for the Special Issue "Bioactive Compounds of Natural Products on Metabolic Disorders and Complications".

Cheang W Curr Issues Mol Biol. 2023; 45(7):5706-5707.

PMID: 37504275 PMC: 10377950. DOI: 10.3390/cimb45070359.

References
1.
Banach M, Patti A, Giglio R, Cicero A, Atanasov A, Bajraktari G . The Role of Nutraceuticals in Statin Intolerant Patients. J Am Coll Cardiol. 2018; 72(1):96-118. DOI: 10.1016/j.jacc.2018.04.040. View

2.
Ebrahimzadeh A, Ebrahimzadeh A, Mirghazanfari S, Hazrati E, Hadi S, Milajerdi A . The effect of ginger supplementation on metabolic profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2022; 65:102802. DOI: 10.1016/j.ctim.2022.102802. View

3.
Stanciauskaite M, Marksa M, Babickaite L, Majiene D, Ramanauskiene K . Comparison of Ethanolic and Aqueous L. Bud Extracts by Different Extraction Methods: Chemical Composition, Antioxidant and Antibacterial Activities. Pharmaceuticals (Basel). 2021; 14(10). PMC: 8541512. DOI: 10.3390/ph14101018. View

4.
Wrobel K, Milewska A, Marczak M, Kozlowski R . Assessment of the Impact of Scientific Reports Published by EFSA and GIS on Functional Foods Newly Placed on the Market in Poland. Int J Environ Res Public Health. 2022; 19(7). PMC: 8998016. DOI: 10.3390/ijerph19074057. View

5.
Hosseini A, Razavi B, Banach M, Hosseinzadeh H . Quercetin and metabolic syndrome: A review. Phytother Res. 2021; 35(10):5352-5364. DOI: 10.1002/ptr.7144. View